Last Updated: November 10, 2026

CLINICAL TRIALS PROFILE FOR GOCOVRI

« Back to Dashboard

All Clinical Trials for GOCOVRI

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04273737 ↗	Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy	Recruiting	Columbia University	Phase 4	2020-02-28	Cerebral palsy (CP) is a common childhood-onset disability associated with motor and cognitive impairments, however most research is focused on motor outcomes. The aim of this study is to determine the effects of Amantadine, a dopaminergic agonist, on cognitive function in adolescents and adults with CP.
NCT04387773 ↗	Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease	Recruiting	Adamas Pharmaceuticals, Inc.	Phase 4	2020-11-05	The purpose of the study is to learn about the effect of GOCOVRI (Amantadine extended release) on activity levels and measures of gait and balance quality in people with Parkinson's disease (PD) and levodopa induced dyskinesia (LID) during daily activities using body-worn sensors.
NCT04387773 ↗	Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease	Recruiting	Oregon Health and Science University	Phase 4	2020-11-05	The purpose of the study is to learn about the effect of GOCOVRI (Amantadine extended release) on activity levels and measures of gait and balance quality in people with Parkinson's disease (PD) and levodopa induced dyskinesia (LID) during daily activities using body-worn sensors.
NCT07125222 ↗	Use of Gocovri to Improve Disability Due to Radiation Encephalopathy	NOT_YET_RECRUITING	Supernus Pharmaceuticals	PHASE2	2025-09-01	A study to assess the effect of Gocovri (extended-release amantidine) to improve disability as assessed by the disability rating scale (DRS) and cognition as assessed by the Montreal Cognitive Assessment (MoCA) test in patients with radiation encephalopathy.
NCT07125222 ↗	Use of Gocovri to Improve Disability Due to Radiation Encephalopathy	NOT_YET_RECRUITING	Weill Medical College of Cornell University	PHASE2	2025-09-01	A study to assess the effect of Gocovri (extended-release amantidine) to improve disability as assessed by the disability rating scale (DRS) and cognition as assessed by the Montreal Cognitive Assessment (MoCA) test in patients with radiation encephalopathy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for GOCOVRI

Condition Name

Chart
Table

Condition Name for GOCOVRI
Intervention	Trials
Cerebral Palsy	1
Parkinson Disease	1
Radiation Encephalopathy	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for GOCOVRI
Intervention	Trials
Parkinson Disease	1
Paralysis	1
Cerebral Palsy	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for GOCOVRI

Trials by Country

Map
Table

Trials by Country for GOCOVRI
Location	Trials
United States	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for GOCOVRI
Location	Trials
New York	2
Oregon	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for GOCOVRI

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for GOCOVRI
Clinical Trial Phase	Trials
PHASE2	1
Phase 4	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for GOCOVRI
Clinical Trial Phase	Trials
Recruiting	2
NOT_YET_RECRUITING	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GOCOVRI

Sponsor Name

Chart
Table

Sponsor Name for GOCOVRI
Sponsor	Trials
Supernus Pharmaceuticals	1
Weill Medical College of Cornell University	1
Columbia University	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for GOCOVRI
Sponsor	Trials
Other	3
UNKNOWN	1
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.